Mitochondrial disease patients' perception of dietary supplements' use
- PMID: 27444792
- PMCID: PMC5031526
- DOI: 10.1016/j.ymgme.2016.07.005
Mitochondrial disease patients' perception of dietary supplements' use
Abstract
Surveys of mitochondrial disease physicians conducted through the Mitochondrial Medicine Society have shown that virtually all providers recommend a variety of dietary supplements as treatments to their patients in an effort to enhance energy production and reduce oxidative stress. In this survey, we asked patients and their parents about their experiences taking these dietary supplements for mitochondrial disease. The survey was disseminated through the North American Mitochondrial Disease Consortium (NAMDC) and the Rare Disease Clinical Research Network (RDCRN) registries and gathered 162 responses. The study ascertained each patient's mitochondrial disease diagnosis, dietary supplements used, adjunct therapy, and effects of the supplements on symptoms and health. Regardless of the specific underlying mitochondrial disease, the majority of the survey respondents stated they are or have been on dietary supplements. Most patients take more than four supplements primarily coenzyme Q10, l-carnitine, and riboflavin. The majority of patients taking supplements reported health benefits from the supplements. The onset of perceived benefits was between 2weeks to 3months of initiating intake. Supplements seem to be safe, with only 28% of patients experiencing mild side-effects and only 5.6% discontinuing their intake due to intolerance. Only 9% of patients had insurance coverage for their supplements and when paying out of pocket, 95% of them spend up to $500/month. Despite the use of concomitant therapies (prescribed medications, physical therapy, diet changes and other), 45.5% of patients think that dietary supplements are the only intervention improving their symptoms. Some limitations of this study include the retrospective collection of data probably associated with substantial recall bias, lack of longitudinal follow up to document pre- and post-supplement clinical status and second hand reports by parents for children which may reflect parents' subjective interpretation of symptoms severity and supplements effect rather than real patients' experience. More extensive prospective studies will help further elucidate this topic.
Keywords: Dietary supplements; Mitochondrial disease; Survey.
Copyright © 2016 Elsevier Inc. All rights reserved.
Similar articles
-
Mitochondrial dysfunction and chronic disease: treatment with natural supplements.Altern Ther Health Med. 2014 Winter;20 Suppl 1:18-25. Altern Ther Health Med. 2014. PMID: 24473982
-
Attitudes toward prevention of mtDNA-related diseases through oocyte mitochondrial replacement therapy.Hum Reprod. 2016 May;31(5):1058-65. doi: 10.1093/humrep/dew033. Epub 2016 Mar 2. Hum Reprod. 2016. PMID: 26936885 Free PMC article.
-
Oral coenzyme Q10 supplementation improves clinical symptoms and recovers pathologic alterations in blood mononuclear cells in a fibromyalgia patient.Nutrition. 2012 Nov-Dec;28(11-12):1200-3. doi: 10.1016/j.nut.2012.03.018. Epub 2012 Aug 14. Nutrition. 2012. PMID: 22898267
-
Dietary supplement consumption among cardiac patients admitted to internal medicine and cardiac wards.Cardiol J. 2015;22(5):510-8. doi: 10.5603/CJ.a2015.0039. Epub 2015 Jun 23. Cardiol J. 2015. PMID: 26100832 Review.
-
[MITOCHONDRIAL DYSFUNCTION: MODERN ASPECTS OF THERAPY (REVIEW)].Georgian Med News. 2015 Jul-Aug;(244-245):78-84. Georgian Med News. 2015. PMID: 26177139 Review. Russian.
Cited by
-
N-acetylcysteine and vitamin E rescue animal longevity and cellular oxidative stress in pre-clinical models of mitochondrial complex I disease.Mol Genet Metab. 2018 Apr;123(4):449-462. doi: 10.1016/j.ymgme.2018.02.013. Epub 2018 Feb 23. Mol Genet Metab. 2018. PMID: 29526616 Free PMC article.
-
Nutritional Interventions for Mitochondrial OXPHOS Deficiencies: Mechanisms and Model Systems.Annu Rev Pathol. 2018 Jan 24;13:163-191. doi: 10.1146/annurev-pathol-020117-043644. Epub 2017 Nov 3. Annu Rev Pathol. 2018. PMID: 29099651 Free PMC article. Review.
-
Current global vitamin and cofactor prescribing practices for primary mitochondrial diseases: Results of a European reference network survey.J Inherit Metab Dis. 2025 Jan;48(1):e12805. doi: 10.1002/jimd.12805. Epub 2024 Nov 11. J Inherit Metab Dis. 2025. PMID: 39529390 Free PMC article.
-
Chronic Progressive External Ophthalmoplegia and Bilateral Vestibular Hypofunction: Balance, Gait, and Eye Movement Before and After Multimodal Chiropractic Care: A Case Study.J Chiropr Med. 2019 Jun;18(2):144-154. doi: 10.1016/j.jcm.2018.11.004. Epub 2019 Jul 1. J Chiropr Med. 2019. PMID: 31367202 Free PMC article.
-
Emerging therapies for mitochondrial diseases.Essays Biochem. 2018 Jul 20;62(3):467-481. doi: 10.1042/EBC20170114. Print 2018 Jul 20. Essays Biochem. 2018. PMID: 29980632 Free PMC article. Review.
References
-
- McFarland R, Taylor RW, Turnbull DM. Mitochondrial disease--its impact, etiology, and pathology. Current topics in developmental biology. 2007;77:113–155. - PubMed
-
- Schaefer AM, McFarland R, Blakely EL, He L, Whittaker RG, Taylor RW, Chinnery PF, Turnbull DM. Prevalence of mitochondrial DNA disease in adults. Annals of neurology. 2008;63(1):35–39. - PubMed
Publication types
MeSH terms
Substances
Grants and funding
LinkOut - more resources
Full Text Sources
Other Literature Sources
Medical